PMV Pharmaceuticals, Inc.

PMVP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001699382

SEC filings (opens in a new tab)

No open-market purchases or sales by PMV Pharmaceuticals, Inc. insiders were filed in the last 90 days; 64 institutions reported holding it in 13F filings for Q2 2026, worth $45.9M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding PMV Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021 All holders in Q2 2021

13F holders of PMVP: Q2 2021 compared with Q3 2021
Measure	Q2 2021	Q3 2021	Change
Holders	86	92	+6
Shares	42.3M	44.0M	+1.74M (+4.1%)
Value	$1.44B	$1.31B	−$132.5M (−9.2%)

New holders (13)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to PMVP in Q3 2021
Institution	Shares	Value	% of portfolio
Price T Rowe Associates Inc	151,778	$4.52M	0.00%
Fred Alger Management, LLC	125,211	$3.73M	0.01%
Driehaus Capital Management LLC	35,000	$1.04M	0.01%
Freed Investment Group	24,880	$741.0K	0.56%
Two Sigma Investments, LP	14,500	$432.0K	0.00%
Marshall Wace, LLP	12,716	$379.0K	0.00%
Los Angeles Capital Management LLC	12,550	$374.0K	0.00%
SG Americas Securities, LLC	9,642	$287.0K	0.00%
PDT Partners, LLC	8,610	$257.0K	0.02%
M&T Bank Corp	8,482	$253.0K	0.00%
Marshall Wace North America L.P.	6,848	$204.0K	0.00%
NEXT Financial Group, Inc	170	$5.00K	0.00%
Signaturefd, LLC	29	$1.00K	0.00%

Sold out (7)

Institutions that held PMV Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of PMVP in Q3 2021
Institution	Shares, Q2 2021	Value, Q2 2021
Wellington Management Group LLP	970,364	$33.1M
Franklin Resources Inc	219,607	$7.50M
Blackstone Group Inc.	23,888	$816.0K
Envestnet Asset Management Inc	7,872	$269.0K
ProShare Advisors LLC	6,804	$232.0K
Handelsbanken Fonder AB	6,000	$205.0K
Evoke Wealth, LLC	3,403	$116.0K